222 related articles for article (PubMed ID: 16783169)
21. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neuropathol Exp Neurol; 2004 Jun; 63(6):641-9. PubMed ID: 15217092
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.
Tremblay C; St-Amour I; Schneider J; Bennett DA; Calon F
J Neuropathol Exp Neurol; 2011 Sep; 70(9):788-98. PubMed ID: 21865887
[TBL] [Abstract][Full Text] [Related]
23. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
[TBL] [Abstract][Full Text] [Related]
24. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease.
Scheff SW; Price DA; Schmitt FA; Scheff MA; Mufson EJ
J Alzheimers Dis; 2011; 24(3):547-57. PubMed ID: 21297265
[TBL] [Abstract][Full Text] [Related]
25. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
Lovell MA; Smith JL; Xiong S; Markesbery WR
Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
[TBL] [Abstract][Full Text] [Related]
26. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
Mosconi L; De Santi S; Li Y; Li J; Zhan J; Tsui WH; Boppana M; Pupi A; de Leon MJ
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):210-21. PubMed ID: 16311757
[TBL] [Abstract][Full Text] [Related]
27. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.
Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ
Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080
[TBL] [Abstract][Full Text] [Related]
28. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
[TBL] [Abstract][Full Text] [Related]
29. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease.
Moreno-Rodriguez M; Perez SE; Nadeem M; Malek-Ahmadi M; Mufson EJ
J Neuroinflammation; 2020 Feb; 17(1):58. PubMed ID: 32066474
[TBL] [Abstract][Full Text] [Related]
30. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
[TBL] [Abstract][Full Text] [Related]
31. Neuropathologic substrate of mild cognitive impairment.
Markesbery WR; Schmitt FA; Kryscio RJ; Davis DG; Smith CD; Wekstein DR
Arch Neurol; 2006 Jan; 63(1):38-46. PubMed ID: 16401735
[TBL] [Abstract][Full Text] [Related]
32. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
Ikonomovic MD; Abrahamson EE; Isanski BA; Wuu J; Mufson EJ; DeKosky ST
Arch Neurol; 2007 Sep; 64(9):1312-7. PubMed ID: 17846271
[TBL] [Abstract][Full Text] [Related]
33. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
34. Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease.
Desikan RS; Cabral HJ; Fischl B; Guttmann CR; Blacker D; Hyman BT; Albert MS; Killiany RJ
AJNR Am J Neuroradiol; 2009 Mar; 30(3):532-8. PubMed ID: 19112067
[TBL] [Abstract][Full Text] [Related]
35. Differential cortical atrophy in subgroups of mild cognitive impairment.
Bell-McGinty S; Lopez OL; Meltzer CC; Scanlon JM; Whyte EM; Dekosky ST; Becker JT
Arch Neurol; 2005 Sep; 62(9):1393-7. PubMed ID: 16157746
[TBL] [Abstract][Full Text] [Related]
36. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
[TBL] [Abstract][Full Text] [Related]
37. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
[TBL] [Abstract][Full Text] [Related]
38. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia.
Heffernan JM; Eastwood SL; Nagy Z; Sanders MW; McDonald B; Harrison PJ
Exp Neurol; 1998 Apr; 150(2):235-9. PubMed ID: 9527892
[TBL] [Abstract][Full Text] [Related]
39. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
[TBL] [Abstract][Full Text] [Related]
40. Spatial patterns of intrinsic brain activity in mild cognitive impairment and Alzheimer's disease: a resting-state functional MRI study.
Wang Z; Yan C; Zhao C; Qi Z; Zhou W; Lu J; He Y; Li K
Hum Brain Mapp; 2011 Oct; 32(10):1720-40. PubMed ID: 21077137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
